Clinicopathological features | n | % |
---|---|---|
Age (median, range) ys | 60 (24–88) |  |
   ≤ 40 | 12 | 12% |
   > 40 | 94 | 88% |
Histological type | Â | Â |
   clear-cell | 11 | 10% |
   endometrioid | 19 | 18% |
   undifferentiated | 5 | 5% |
   mixed | 14 | 13% |
   mucinous | 3 | 3% |
   serous-papillary | 54 | 51% |
FIGO stage | Â | Â |
   ≤ IIB | 25 | 24% |
   > IIB | 81 | 76% |
Histological grade | Â | Â |
   G1 | 7 | 7% |
   G2 | 13 | 12% |
   G3 | 86 | 81% |
Residual tumor (TR), cm | Â | Â |
   TR = 0 | 42 | 40% |
   TR ≥ 0.5 | 64 | 60% |
Ascites | Â | Â |
   yes | 62 | 58% |
   no | 44 | 42% |
Lymph nodal involvement | Â | Â |
   negative | 53 | 50% |
   positive | 28 | 26% |
   missing | 25 | 24% |
Preoperatory CA125 level | Â | Â |
   < Threshold** | 11 | 10% |
   ≥ Threshold** | 92 | 87% |
   missing | 3 | 3% |